BioMarin Shares Jump 5% After Global Patent Settlement With Ascendis

insidermonkey.com · 2026-09-12

BioMarin Pharmaceutical Inc.

TickrTrends take: Ascendis Pharma recently achieved a global patent settlement with BioMarin that prompted market movement in BioMarin shares, representing a significant development in the company's intellectual property landscape. For valuation-focused readers, this settlement eliminates a source of legal uncertainty that could have carried substantial financial implications for Ascendis going forward. With TickrTrends' verdict currently awaiting full valuation, investors monitoring this Healthcare sector company should track how this patent resolution affects the company's future earnings potential and cash flow projections.

Read the full story at insidermonkey.com →